Showing results (381-390 of 604) with videos related to

Sort By:
Pageof 61
Nature Communications|November 2, 2017
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivitySebastian Palmqvist, Michael Schöll, Olof Strandberg, et al.
Frontiers in Computational Neuroscience|January 27, 2022
Comparison of Two-Dimensional- and Three-Dimensional-Based U-Net Architectures for Brain Tissue Classification in One-Dimensional Brain CTMeera Srikrishna, Rolf A Heckemann, Joana B Pereira, et al.
Physical Review Letters|November 5, 2004
Electron-vibron coupling in high-resolution X-Ray absorption spectra of organic materials: NTCDA on Ag(111)A Schöll, Y Zou, L Kilian, et al.
Archives of Gynecology and Obstetrics|May 26, 2018
Prospective cohort study of pregnancy complications and birth outcomes in women with asthmaNasrin Fazel, Michael Kundi, Erika Jensen-Jarolim, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 7, 2003
Phage-displayed Bet mim 1, a mimotope of the major birch pollen allergen Bet v 1, induces B cell responses to the natural antigen using bystander T cell helpI Schöll, U Wiedermann, E Förster-Waldl, et al.
Neurology|July 30, 2017
In vivo retention of 18F-AV-1451 in corticobasal syndromeRuben Smith, Michael Schöll, Håkan Widner, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|June 6, 2008
Anti-acids lead to immunological and morphological changes in the intestine of BALB/c mice similar to human food allergyIsabella Pali-Schöll, Ali O Yildirim, Ute Ackermann, et al.
The Journal of Prevention of Alzheimer'S Disease|June 5, 2026
Plasma brain-derived p-Tau217 outperforms other p-Tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burdenJoyce R Chong, Saima Hilal, Narayanaswamy Venketasubramanian, et al.
Nature Reviews. Drug Discovery|April 4, 2025
Biomarker-guided decision making in clinical drug development for neurodegenerative disordersJeffrey L Cummings, Charlotte E Teunissen, Brian K Fiske, et al.
Pageof 61